News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Supriyadi Hafiz

Advertisement

Supriyadi Hafiz is the senior scientist formulation for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.

Articles by Supriyadi Hafiz

Seven Trends Shaping the Future of Pharmaceutical Formulation Development

ByCan Araman,Moritz Beck-Broichsitter,Nelli Erwin ,Supriyadi Hafiz ,Adela Kasselkus ,Thomas Kipping ,David Luedeker ,Aditi Mehta ,Lena Mueller,Sara S. Nogueira,Tobias Rosenkranz,Eleni Samaridou,Johanna Simon
October 7th 2022

Emerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.

Advertisement

Latest Updated Articles

  • Seven Trends Shaping the Future of Pharmaceutical Formulation Development
    Seven Trends Shaping the Future of Pharmaceutical Formulation Development

    Published: October 7th 2022 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development

2

AI and Human Collaboration Essential for Bio/pharma Innovation

3

Sustainability and Stability in Excipients

4

Centralizing AI Strategy, Ensuring Process Integrity, and Balancing Quick Wins with Long-Term Drug Design in Bio/pharma

5

Excipient Innovation, Safer Solvents, and Supply Chain Resilience

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us